| GO ID | Ontology | GO Term | Term Definition |
Proteins |
GO:1900226 | BP | negative regulation of NLRP3 inflammasome complex assembly | Any process that stops, prevents or reduces the frequency, rate or extent of NLRP3 inflammasome complex assembly. |
SIRT2 |
GO:1900227 | BP | positive regulation of NLRP3 inflammasome complex assembly | Any process that activates or increases the frequency, rate or extent of NLRP3 inflammasome complex assembly. |
TLR4, CD36 |
GO:1900235 | BP | negative regulation of Kit signaling pathway | Any process that stops, prevents or reduces the frequency, rate or extent of Kit signaling pathway. |
RABGEF1 |
GO:1900242 | BP | regulation of synaptic vesicle endocytosis | Any process that modulates the frequency, rate or extent of synaptic vesicle endocytosis. |
BTBD9 |
GO:1900243 | BP | negative regulation of synaptic vesicle endocytosis | Any process that stops, prevents or reduces the frequency, rate or extent of synaptic vesicle endocytosis. |
SYT11 |
GO:1900244 | BP | positive regulation of synaptic vesicle endocytosis | Any process that activates or increases the frequency, rate or extent of synaptic vesicle endocytosis. |
TOR1A, NLGN1 |
GO:1900246 | BP | positive regulation of RIG-I signaling pathway | Any process that activates or increases the frequency, rate or extent of RIG-I signaling pathway. |
PUM1, PUM2 |
GO:1900248 | BP | negative regulation of cytoplasmic translational elongation | Any process that stops, prevents or reduces the frequency, rate or extent of cytoplasmic translational elongation. |
CPEB2, CPEB3 |
GO:1900260 | BP | negative regulation of RNA-directed RNA polymerase activity | Any process that stops, prevents or reduces the frequency, rate or extent of RNA-directed RNA polymerase activity. |
EIF4A2 |
GO:1900264 | BP | positive regulation of DNA-directed DNA polymerase activity | Any process that activates or increases the frequency, rate or extent of DNA-directed DNA polymerase activity. |
RFC4, RFC2, RFC5, RFC3, CHTF18, DSCC1 |
GO:1900271 | BP | regulation of long-term synaptic potentiation | Any process that modulates the frequency, rate or extent of long-term synaptic potentiation. |
PAIP2 |
GO:1900273 | BP | positive regulation of long-term synaptic potentiation | Any process that activates or increases the frequency, rate or extent of long-term synaptic potentiation. |
STAU1, DRD2, CREB1, GRIN2A, EIF2AK4 |
GO:1900275 | BP | negative regulation of phospholipase C activity | Any process that stops, prevents or reduces the frequency, rate or extent of phospholipase C activity. |
BICD1 |
GO:1900276 | BP | regulation of proteinase activated receptor activity | Any process that modulates the frequency, rate or extent of proteinase activated receptor activity. |
BICD1 |
GO:1900281 | BP | positive regulation of CD4-positive, alpha-beta T cell costimulation | Any process that activates or increases the frequency, rate or extent of CD4-positive, alpha-beta T cell costimulation. |
TNFSF4 |
GO:1900363 | BP | regulation of mRNA polyadenylation | Any process that modulates the frequency, rate or extent of mRNA polyadenylation. |
SNRPA |
GO:1900364 | BP | negative regulation of mRNA polyadenylation | Any process that stops, prevents or reduces the frequency, rate or extent of mRNA polyadenylation. |
SUPT5H, CCNT1, ZC3H14 |
GO:1900365 | BP | positive regulation of mRNA polyadenylation | Any process that activates or increases the frequency, rate or extent of mRNA polyadenylation. |
CPEB3 |
GO:1900387 | BP | negative regulation of cell-cell adhesion by negative regulation of transcription from RNA polymerase II promoter | A negative regulation of transcription from RNA polymerase II promoter that results in negative regulation of cell-cell adhesion. |
SNAI2 |
GO:1900407 | BP | regulation of cellular response to oxidative stress | Any process that modulates the frequency, rate or extent of cellular response to oxidative stress. |
PARK2, PINK1, FUT8 |
GO:1900424 | BP | regulation of defense response to bacterium | Any process that modulates the frequency, rate or extent of defense response to bacterium. |
SYT11, FOXP1 |
GO:1900425 | BP | negative regulation of defense response to bacterium | Any process that stops, prevents or reduces the frequency, rate or extent of defense response to bacterium. |
SIRT2 |
GO:1900453 | BP | negative regulation of long term synaptic depression | Any process that stops, prevents or reduces the frequency, rate or extent of long term synaptic depression. |
ADORA1, FMR1 |
GO:1900483 | BP | regulation of protein targeting to vacuolar membrane | Any process that modulates the frequency, rate or extent of protein targeting to vacuolar membrane. |
VAMP7 |
GO:1900535 | BP | palmitic acid biosynthetic process | The chemical reactions and pathways resulting in the formation of palmitic acid. |
ACOT7 |
GO:1900625 | BP | positive regulation of monocyte aggregation | Any process that activates or increases the frequency, rate or extent of monocyte aggregation. |
CD44, NR4A3, HAS2 |
GO:1900737 | BP | negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway | Any process that stops, prevents or reduces the frequency, rate or extent of phospholipase C-activating G-protein coupled receptor signaling pathway. |
BICD1 |
GO:1900738 | BP | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway | Any process that activates or increases the frequency, rate or extent of phospholipase C-activating G-protein coupled receptor signaling pathway. |
F2, GPR27 |
GO:1900740 | BP | positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway | Any process that activates or increases the frequency, rate or extent of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway. |
BCL2L11, TP53, BCL2, YWHAB, SFN, MAPK8, BID, YWHAE, YWHAZ, DYNLL1, E2F1, YWHAH, TP53BP2, PMAIP1, TFDP1, CASP8, BAD |
GO:1900744 | BP | regulation of p38MAPK cascade | Any process that modulates the frequency, rate or extent of p38MAPK cascade. |
PER1, HGF, ULK4 |
GO:1900745 | BP | positive regulation of p38MAPK cascade | Any process that activates or increases the frequency, rate or extent of p38MAPK cascade. |
GADD45B, GADD45G, BMP2, VEGFA, GADD45A, LEP, XDH, MAP3K5, PRMT1, MAP3K4 |
GO:1900747 | BP | negative regulation of vascular endothelial growth factor signaling pathway | Any process that stops, prevents or reduces the frequency, rate or extent of vascular endothelial growth factor signaling pathway. |
DCN, XDH |
GO:1900748 | BP | positive regulation of vascular endothelial growth factor signaling pathway | Any process that activates or increases the frequency, rate or extent of vascular endothelial growth factor signaling pathway. |
MYO1C, CCBE1 |
GO:1900825 | BP | regulation of membrane depolarization during cardiac muscle cell action potential | Any process that modulates the frequency, rate or extent of membrane depolarization during a cardiac muscle cell action potential. |
GJA5, RANGRF |
GO:1900827 | BP | positive regulation of membrane depolarization during cardiac muscle cell action potential | Any process that activates or increases the frequency, rate or extent of membrane depolarization during a cardiac muscle cell action potential. |
ANK3 |
GO:1901003 | BP | negative regulation of fermentation | Any process that stops, prevents or reduces the frequency, rate or extent of fermentation. |
PRKCDBP |
GO:1901016 | BP | regulation of potassium ion transmembrane transporter activity | Any process that modulates the frequency, rate or extent of potassium ion transmembrane transporter activity. |
WWP2, YWHAE, FHL1, NEDD4L |
GO:1901017 | BP | negative regulation of potassium ion transmembrane transporter activity | Any process that stops, prevents or reduces the frequency, rate or extent of potassium ion transmembrane transporter activity. |
ACTN2, NEDD4L, CAB39 |
GO:1901018 | BP | positive regulation of potassium ion transmembrane transporter activity | Any process that activates or increases the frequency, rate or extent of potassium ion transmembrane transporter activity. |
ATP1B1, ACTN2, ATP1B3, ANK2 |
GO:1901019 | BP | regulation of calcium ion transmembrane transporter activity | Any process that modulates the frequency, rate or extent of calcium ion transmembrane transporter activity. |
ANK2 |
GO:1901020 | BP | negative regulation of calcium ion transmembrane transporter activity | Any process that stops, prevents or reduces the frequency, rate or extent of calcium ion transmembrane transporter activity. |
PLN |
GO:1901021 | BP | positive regulation of calcium ion transmembrane transporter activity | Any process that activates or increases the frequency, rate or extent of calcium ion transmembrane transporter activity. |
ANK2 |
GO:1901026 | BP | ripoptosome assembly involved in necroptotic process | The aggregation, arrangement and bonding together of ripoptosome components leading to a necroptotic process. |
RIPK1, SIRT2 |
GO:1901029 | BP | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | Any process that stops, prevents or reduces the frequency, rate or extent of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway. |
SLC25A5, HSPA1A, HSPA1B |
GO:1901030 | BP | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | Any process that activates or increases the frequency, rate or extent of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway. |
ZNF205, GSK3B, BID, BAX |
GO:1901031 | BP | regulation of response to reactive oxygen species | Any process that modulates the frequency, rate or extent of response to reactive oxygen species. |
SESN2, SESN3, SESN1 |
GO:1901074 | BP | regulation of engulfment of apoptotic cell | Any process that modulates the frequency, rate or extent of engulfment of apoptotic cell. |
ALOX15 |
GO:1901077 | BP | regulation of relaxation of muscle | Any process that modulates the frequency, rate or extent of relaxation of muscle. |
SRI |
GO:1901094 | BP | negative regulation of protein homotetramerization | Any process that stops, prevents or reduces the frequency, rate or extent of protein homotetramerization. |
PEX14 |
GO:1901097 | BP | negative regulation of autophagosome maturation | Any process that stops, prevents or reduces the frequency, rate or extent of autophagosome maturation. |
UBQLN4 |
GO:1901098 | BP | positive regulation of autophagosome maturation | Any process that activates or increases the frequency, rate or extent of autophagosome maturation. |
ADRB2, CALCOCO2 |
GO:1901142 | BP | insulin metabolic process | The chemical reactions and pathways involving insulin. |
ERN1, IDE |
GO:1901143 | BP | insulin catabolic process | The chemical reactions and pathways resulting in the breakdown of insulin. |
IDE |
GO:1901164 | BP | negative regulation of trophoblast cell migration | Any process that stops, prevents or reduces the frequency, rate or extent of trophoblast cell migration. |
TIMP1, ARHGDIB |
GO:1901165 | BP | positive regulation of trophoblast cell migration | Any process that activates or increases the frequency, rate or extent of trophoblast cell migration. |
ACVR1B, C1QBP, SMURF2 |
GO:1901166 | BP | neural crest cell migration involved in autonomic nervous system development | Any neural crest cell migration that is involved in autonomic nervous system development. |
NRP1, SEMA3A |
GO:1901184 | BP | regulation of ERBB signaling pathway | Any process that modulates the frequency, rate or extent of ERBB signaling pathway. |
SH3TC2 |
GO:1901187 | BP | regulation of ephrin receptor signaling pathway | Any process that modulates the frequency, rate or extent of ephrin receptor signaling pathway. |
ANKS1A |
GO:1901194 | BP | negative regulation of formation of translation preinitiation complex | Any process that stops, prevents or reduces the frequency, rate or extent of formation of translation preinitiation complex. |
RPL13A |
GO:1901201 | BP | regulation of extracellular matrix assembly | Any process that modulates the frequency, rate or extent of extracellular matrix assembly. |
AGT, NOTCH1 |
GO:1901203 | BP | positive regulation of extracellular matrix assembly | Any process that activates or increases the frequency, rate or extent of extracellular matrix assembly. |
TGFB1, SOX9, SMAD3, RGCC |
GO:1901205 | BP | negative regulation of adrenergic receptor signaling pathway involved in heart process | Any process that stops, prevents or reduces the frequency, rate or extent of a cardiac adrenergic receptor signaling pathway. |
ATP2B4 |
GO:1901214 | BP | regulation of neuron death | Any process that modulates the frequency, rate or extent of neuron death. |
RAB29, CLU, CCL5, EPHB1, RRAS2, DHCR24, SARM1, CHP1, TBK1 |
GO:1901215 | BP | negative regulation of neuron death | Any process that stops, prevents or reduces the frequency, rate or extent of neuron death. |
PARK2, APOE, IL6, CREB1, AKT1, CTNNB1, SERPINF1, SNCA, STAT3, PSMC1, CDK5, HSF1, REL, PPARA, TMEM259, SORL1, CHMP4B, ATP13A2, PPARGC1A |
GO:1901216 | BP | positive regulation of neuron death | Any process that activates or increases the frequency, rate or extent of neuron death. |
EIF2S1, PARP1, CLU, ELK1, GSK3B, PICALM, TP53BP2, BAD, MAP3K5, DDIT4 |
GO:1901222 | BP | regulation of NIK/NF-kappaB signaling | Any process that modulates the frequency, rate or extent of NIK/NF-kappaB signaling. |
UACA, AKIP1, PTPN22 |
GO:1901223 | BP | negative regulation of NIK/NF-kappaB signaling | Any process that stops, prevents or reduces the frequency, rate or extent of NIK/NF-kappaB signaling. |
TSPAN6, RELA, HDAC7, ADIPOR1 |
GO:1901224 | BP | positive regulation of NIK/NF-kappaB signaling | Any process that activates or increases the frequency, rate or extent of NIK/NF-kappaB signaling. |
ACTN4, TNF, CALR, RC3H2 |
GO:1901253 | BP | negative regulation of intracellular transport of viral material | Any process that stops, prevents or reduces the frequency, rate or extent of intracellular transport of viral material. |
BST2 |
GO:1901254 | BP | positive regulation of intracellular transport of viral material | Any process that activates or increases the frequency, rate or extent of intracellular transport of viral material. |
FMR1 |
GO:1901255 | BP | nucleotide-excision repair involved in interstrand cross-link repair | Any nucleotide-excision repair that is involved in interstrand cross-link repair. |
XPA, ERCC4 |
GO:1901256 | BP | regulation of macrophage colony-stimulating factor production | Any process that modulates the frequency, rate or extent of macrophage colony-stimulating factor production. |
FOXP1 |
GO:1901264 | BP | carbohydrate derivative transport | The directed movement of a carbohydrate derivative into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. |
SLC35E3 |
GO:1901292 | BP | nucleoside phosphate catabolic process | The chemical reactions and pathways resulting in the breakdown of a nucleoside phosphate. |
NUDT15 |
GO:1901296 | BP | negative regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment | Any process that stops, prevents or reduces the frequency, rate or extent of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment. |
DKK1 |
GO:1901299 | BP | negative regulation of hydrogen peroxide-mediated programmed cell death | Any process that stops, prevents or reduces the frequency, rate or extent of hydrogen peroxide-mediated programmed cell death. |
MET, HGF |
GO:1901300 | BP | positive regulation of hydrogen peroxide-mediated programmed cell death | Any process that activates or increases the frequency, rate or extent of hydrogen peroxide-mediated programmed cell death. |
FOXO3, PAWR, HDAC6 |
GO:1901303 | BP | negative regulation of cargo loading into COPII-coated vesicle | Any process that stops, prevents or reduces the frequency, rate or extent of cargo loading into a COPII-coated vesicle. |
INSIG1 |
GO:1901315 | BP | negative regulation of histone H2A K63-linked ubiquitination | Any process that stops, prevents or reduces the frequency, rate or extent of histone H2A K63-linked ubiquitination. |
UBR5, OTUB1 |
GO:1901318 | BP | negative regulation of flagellated sperm motility | Any process that stops, prevents or reduces the frequency, rate or extent of flagellated sperm motility. |
RGN |
GO:1901350 | BP | cell-cell signaling involved in cell-cell junction organization | Any cell-cell signaling that is involved in cell-cell junction organization. |
TJP1 |
GO:1901355 | BP | response to rapamycin | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a rapamycin stimulus. |
HNRNPD |
GO:1901373 | BP | lipid hydroperoxide transport | The directed movement of a lipid hydroperoxide into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. |
SCP2 |
GO:1901374 | BP | acetate ester transport | The directed movement of an acetate ester into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. |
SLC22A1 |
GO:1901379 | BP | regulation of potassium ion transmembrane transport | Any process that modulates the frequency, rate or extent of potassium ion transmembrane transport. |
PRNP, DPP6, KCNH2, KCNIP2 |
GO:1901380 | BP | negative regulation of potassium ion transmembrane transport | Any process that stops, prevents or reduces the frequency, rate or extent of potassium ion transmembrane transport. |
CAV1, KCNH2, NEDD4L, CAB39 |
GO:1901381 | BP | positive regulation of potassium ion transmembrane transport | Any process that activates or increases the frequency, rate or extent of potassium ion transmembrane transport. |
KCNH2, AKAP6 |
GO:1901382 | BP | regulation of chorionic trophoblast cell proliferation | Any process that modulates the frequency, rate or extent of chorionic trophoblast cell proliferation. |
BOK |
GO:1901385 | BP | regulation of voltage-gated calcium channel activity | Any process that modulates the frequency, rate or extent of voltage-gated calcium channel activity. |
DMD, CACNB3, AHNAK, STAC |
GO:1901386 | BP | negative regulation of voltage-gated calcium channel activity | Any process that stops, prevents or reduces the frequency, rate or extent of voltage-gated calcium channel activity. |
DRD2, OPRL1, FMR1 |
GO:1901387 | BP | positive regulation of voltage-gated calcium channel activity | Any process that activates or increases the frequency, rate or extent of voltage-gated calcium channel activity. |
EHD3 |
GO:1901407 | BP | regulation of phosphorylation of RNA polymerase II C-terminal domain | Any process that modulates the frequency, rate or extent of phosphorylation of RNA polymerase II C-terminal domain. |
BRD4 |
GO:1901409 | BP | positive regulation of phosphorylation of RNA polymerase II C-terminal domain | Any process that activates or increases the frequency, rate or extent of phosphorylation of RNA polymerase II C-terminal domain. |
CCNT1, CCNT2, CCNL2, CCNL1 |
GO:1901475 | BP | pyruvate transmembrane transport | The directed movement of pyruvate across a membrane. |
SLC16A7 |
GO:1901491 | BP | negative regulation of lymphangiogenesis | Any process that stops, prevents or reduces the frequency, rate or extent of lymphangiogenesis. |
FOXC1 |
GO:1901492 | BP | positive regulation of lymphangiogenesis | Any process that activates or increases the frequency, rate or extent of lymphangiogenesis. |
VEGFC, CCBE1 |
GO:1901509 | BP | regulation of endothelial tube morphogenesis | Any process that modulates the frequency, rate or extent of endothelial tube morphogenesis. |
ADAMTS12, FOXP1 |
GO:1901522 | BP | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus | Any positive regulation of transcription from RNA polymerase II promoter that is involved in cellular response to chemical stimulus. |
SMAD9, BMP2, DLX5, SMAD4, RUNX2, SMAD1, SMAD5 |
GO:1901529 | BP | positive regulation of anion channel activity | Any process that activates or increases the frequency, rate or extent of anion channel activity. |
TCAF1 |
GO:1901532 | BP | regulation of hematopoietic progenitor cell differentiation | Any process that modulates the frequency, rate or extent of hematopoietic progenitor cell differentiation. |
PDCD2 |